Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.

Sinn PL, Coffin JE, Ayithan N, Holt KH, Maury W.

Methods Mol Biol. 2017;1628:65-78. doi: 10.1007/978-1-4939-7116-9_5.

2.

A mouse knockout library for secreted and transmembrane proteins.

Tang T, Li L, Tang J, Li Y, Lin WY, Martin F, Grant D, Solloway M, Parker L, Ye W, Forrest W, Ghilardi N, Oravecz T, Platt KA, Rice DS, Hansen GM, Abuin A, Eberhart DE, Godowski P, Holt KH, Peterson A, Zambrowicz BP, de Sauvage FJ.

Nat Biotechnol. 2010 Jul;28(7):749-55. doi: 10.1038/nbt.1644. Epub 2010 Jun 20.

PMID:
20562862
3.

High-throughput screening of mouse knockout lines identifies true lean and obese phenotypes.

Brommage R, Desai U, Revelli JP, Donoviel DB, Fontenot GK, Dacosta CM, Smith DD, Kirkpatrick LL, Coker KJ, Donoviel MS, Eberhart DE, Holt KH, Kelly MR, Paradee WJ, Philips AV, Platt KA, Suwanichkul A, Hansen GM, Sands AT, Zambrowicz BP, Powell DR.

Obesity (Silver Spring). 2008 Oct;16(10):2362-7. doi: 10.1038/oby.2008.361. Epub 2008 Jul 31.

4.

High-throughput mouse knockouts provide a functional analysis of the genome.

Friddle CJ, Abuin A, Ramirez-Solis R, Richter LJ, Buxton EC, Edwards J, Finch RA, Gupta A, Hansen G, Holt KH, Hu Y, Huang W, Jaing C, Key BW Jr, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Newhouse M, Perry T, Platt KA, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Tran D, Wann ER, Walke W, Wallace JD, Xu N, Zhu Q, Person C, Sands AT, Zambrowicz BP.

Cold Spring Harb Symp Quant Biol. 2003;68:311-5. No abstract available.

PMID:
15338631
5.

Full-speed mammalian genetics: in vivo target validation in the drug discovery process.

Abuin A, Holt KH, Platt KA, Sands AT, Zambrowicz BP.

Trends Biotechnol. 2002 Jan;20(1):36-42. Review.

PMID:
11742676
6.

Biosynthesis of dystroglycan: processing of a precursor propeptide.

Holt KH, Crosbie RH, Venzke DP, Campbell KP.

FEBS Lett. 2000 Feb 18;468(1):79-83.

7.

Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex.

Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, Grady RM, Chamberlain JS, Sanes JR, Campbell KP.

J Cell Biol. 1999 Apr 5;145(1):153-65.

8.

Assembly of the sarcoglycan complex. Insights for muscular dystrophy.

Holt KH, Campbell KP.

J Biol Chem. 1998 Dec 25;273(52):34667-70.

9.

Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.

Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R, Campbell KP.

J Cell Biol. 1998 Sep 21;142(6):1461-71.

10.

Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer.

Holt KH, Lim LE, Straub V, Venzke DP, Duclos F, Anderson RD, Davidson BL, Campbell KP.

Mol Cell. 1998 May;1(6):841-8.

11.

Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation.

Waters SB, Chen D, Kao AW, Okada S, Holt KH, Pessin JE.

J Biol Chem. 1996 Jul 26;271(30):18224-30.

12.

Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex.

Holt KH, Waters SB, Okada S, Yamauchi K, Decker SJ, Saltiel AR, Motto DG, Koretzky GA, Pessin JE.

J Biol Chem. 1996 Apr 5;271(14):8300-6.

13.

SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways.

Dong Chen, Waters SB, Holt KH, Pessin JE.

J Biol Chem. 1996 Mar 15;271(11):6328-32.

15.

Insulin stimulation of a MEK-dependent but ERK-independent SOS protein kinase.

Holt KH, Kasson BG, Pessin JE.

Mol Cell Biol. 1996 Feb;16(2):577-83.

16.

Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex.

Waters SB, Holt KH, Ross SE, Syu LJ, Guan KL, Saltiel AR, Koretzky GA, Pessin JE.

J Biol Chem. 1995 Sep 8;270(36):20883-6.

17.

Supplemental Content

Support Center